Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Anticancer Research|September 15, 2019
Renin-Angiotensin Inhibition in Combating Malignancy: A ReviewTalma Rosenthal, Irene GavrasProgress in Cardiovascular Diseases|May 23, 2006
Fixed-drug combinations as first-line treatment for hypertensionTalma Rosenthal, Irene GavrasCurrent Controlled Trials in Cardiovascular Medicine|January 25, 2002
Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?Irene Gavras, Haralambos GavrasCurrent Hypertension Reports|July 20, 2004
Combination therapy as first-line treatment for hypertensionIrene Gavras, Talma RosenthalAmerican Journal of Therapeutics|August 1, 1996
What Data Are Required to Adopt New Antihypertensive Agents?Irene Gavras, Haralambos GavrasJournal of Hypertension|January 10, 2012
'Volume-expanded' hypertension: the effect of fluid overload and the role of the sympathetic nervous system in salt-dependent hypertensionIrene Gavras, Haralambos GavrasHypertension Research : Official Journal of the Japanese Society of Hypertension|May 28, 2010
Cardioprotective properties of bradykinin: role of the B(2) receptorAthanasios J Manolis, Maria E Marketou, Irene Gavras, et al.Journal of Hypertension|April 26, 2003
Central alpha2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertensionEkaterina Kintsurashvili, Conrado Johns, Ivana Ignjacev, et al.Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 26, 2006
Central plasmid antisense administration reduces blood pressure inhibiting alpha2B adrenoceptor gene expression in spontaneously hypertensive rats in vivoHelen Triantafyllidi, Ekaterina Kintsurashvili, Conrado Johns, et al.American Journal of Hypertension|October 31, 2006
Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive ratsSherene M Shenouda, Conrado Johns, Ekaterina Kintsurashvili, et al.Pageof 3